Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shetty

Showing results (771-780 of 780) with videos related to

Pageof 78
Sort By:
You have reached the last page of results.This site can display upto 780 results.
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 17, 2021
Maternal crack cocaine use in rats leads to depressive- and anxiety-like behavior, memory impairment, and increased seizure susceptibility in the offspringAmanda Larissa Dias Pacheco, Igor Santana de Melo, Fernanda Maria Araújo de Souza, et al.
Lancet (London, England)|June 13, 2023
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trialUwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini, et al.
Annals of Neurology|March 26, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 SeverityGina S Perez Giraldo, Sareen T Ali, Anthony K Kang, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Cell Transplantation|April 12, 2018
Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)Hongyun Huang, Wise Young, Lin Chen, et al.
JAMA Oncology|September 7, 2023
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, Amanda Ramos da Cunha, Kelly Compton, et al.
Journal of Extracellular Vesicles|January 15, 2019
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesClotilde Théry, Kenneth W Witwer, Elena Aikawa, et al.
JAMA Oncology|December 30, 2021
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Jonathan M Kocarnik, Kelly Compton, et al.
JAMA Neurology|May 23, 2025
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021, Ilari Rautalin, Victor Volovici, et al.
Pageof 78

Showing results (771-780 of 780) with videos related to

Sort By:
Pageof 78
You have reached the last page of results.This site can display upto 780 results.
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 17, 2021
Maternal crack cocaine use in rats leads to depressive- and anxiety-like behavior, memory impairment, and increased seizure susceptibility in the offspringAmanda Larissa Dias Pacheco, Igor Santana de Melo, Fernanda Maria Araújo de Souza, et al.
Lancet (London, England)|June 13, 2023
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trialUwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini, et al.
Annals of Neurology|March 26, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 SeverityGina S Perez Giraldo, Sareen T Ali, Anthony K Kang, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Cell Transplantation|April 12, 2018
Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)Hongyun Huang, Wise Young, Lin Chen, et al.
JAMA Oncology|September 7, 2023
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, Amanda Ramos da Cunha, Kelly Compton, et al.
Journal of Extracellular Vesicles|January 15, 2019
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesClotilde Théry, Kenneth W Witwer, Elena Aikawa, et al.
JAMA Oncology|December 30, 2021
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Jonathan M Kocarnik, Kelly Compton, et al.
JAMA Neurology|May 23, 2025
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021, Ilari Rautalin, Victor Volovici, et al.
Pageof 78